Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11
- 1 May 1998
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 127 (1-2) , 99-106
- https://doi.org/10.1016/s0304-3835(98)00031-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Physical properties and tissue distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomesAdvanced Drug Delivery Reviews, 1997
- Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycinCancer Letters, 1997
- The preparation and the tissue distribution of liposomal CPT-11.Drug Delivery System, 1996
- Characterisation and Clinical Management of CPT-11 (Irinotecan)-induced Adverse Events: The European PerspectiveEuropean Journal Of Cancer, 1996
- Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.Journal of Clinical Oncology, 1995
- The Effect of Dose on the Distribution of Adriamycin Encapsulated in Polyethyleneglycol-Coated LiposomesJournal of Drug Targeting, 1995
- Enhanced Antitumor Efficacy of a Combination of CPT‐11, a New Derivative of Camptothecin, and Cisplatin against Human Lung Tumor XenograftsJapanese Journal of Cancer Research, 1993
- Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous InfusionJNCI Journal of the National Cancer Institute, 1992
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965